KALA BIO, Inc. (KALA)
NASDAQ: KALA · Real-Time Price · USD
0.1160
+0.0039 (3.48%)
May 6, 2026, 1:41 PM EDT - Market open
KALA BIO Market Cap
KALA BIO has a market cap or net worth of $107.82 million as of May 6, 2026. Its market cap has increased by 408.59% in one year.
Market Cap
107.82M
Enterprise Value
96.64M
1-Year Change
408.59%
Ranking
Category
Stock Price
$0.12
Market Cap Chart
Since July 20, 2017, KALA BIO's market cap has decreased from $430.50M to $107.82M, a decrease of -74.95%. That is a compound annual growth rate of -14.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 104.10M | 2,163.04% |
| Dec 31, 2025 | 4.60M | -85.63% |
| Dec 31, 2024 | 32.00M | 69.31% |
| Dec 29, 2023 | 18.90M | -67.36% |
| Dec 30, 2022 | 57.90M | -26.99% |
| Dec 31, 2021 | 79.30M | -79.14% |
| Dec 31, 2020 | 380.20M | 198.20% |
| Dec 31, 2019 | 127.50M | -22.87% |
| Dec 31, 2018 | 165.30M | -63.54% |
| Dec 29, 2017 | 453.40M | 5.32% |
| Jul 20, 2017 | 430.50M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pyxis Oncology | 108.07M |
| Verrica Pharmaceuticals | 107.71M |
| Anixa Biosciences | 105.28M |
| NeOnc Technologies Holdings | 102.27M |
| NRx Pharmaceuticals | 102.08M |
| Oncolytics Biotech | 101.04M |
| Biomea Fusion | 99.05M |
| Cue Biopharma | 99.03M |